nejm tirzepatide vs. Semaglutide: Which Weight Loss Drug Works Better? [May 2025 Study Explained] The results are finally in
Pay in 4 interest-free payments of $6.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
The results are finally in for the first direct head to head GLP 1 trial. For months, consumers have had to rely on indirect comparisons between Tirzepatide and Semaglutide. Now, the New England Journal of In patients with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was noninferior to dulaglutide with respect to major cardiovascular events. , , Read the full SURPASS CVOT Tirzepatide: Breakthrough in Obesity and Diabetes Management (SURMOUNT 1 Study at 3 years) gutsandgrowth Tirzepatide vs Semaglutide for Obesity NEJM, May 2025 Relevant to endocrinology, internal medicine, cardiology, obesity medicine Tirzepatide: 20.2% weight loss at 72 wks Semaglutide: 13.7% Greater waist reduction
Store: larengifo.com · Domain: larengifo.com
![nejm tirzepatide vs. Semaglutide: Which Weight Loss Drug Works Better? [May 2025 Study Explained] The results are finally in](https://gutsandgrowth.com/wp-content/uploads/2025/03/image-55.png)
![nejm tirzepatide vs. Semaglutide: Which Weight Loss Drug Works Better? [May 2025 Study Explained] The results are finally in](https://lookaside.fbsbx.com/lookaside/crawler/threads/DJj0ORnsEZp/0/image.jpg)

























